Hints and tips:
...Accolade struck a deal with basketball player James Harden to launch a signature wine collection to drive US sales last year....
...HoldCo calculates that US Bank’s capital ratios, when factoring in likely regulatory changes, are just above 6 per cent, and below the 7 per cent minimum threshold required of the largest banks....
...Let’s look at the board and holdco quickly....
...Regulatory filings in California show that Mr Kalanick created a new holding company, CSS Intl HoldCo, last August, apparently to act as a vehicle for dealmaking abroad....
...Apax-backed cloud computing company ECi Software is set to raise $740m in new loans, while TPG’s broadband outfit, Radiate Holdco, is in the market for $500m....
...A planned takeover of Allergan by US drugmaker Pfizer in 2015 fell through a year later when Barack Obama’s administration took steps to scupper a deal which was designed to help Pfizer escape paying US...
...Deleverage was sizeable, with net debt falling to £1.2bn (inc deeply subordinated bonds, pre IFRS16), or down £343m YoY....
...It was once a Wall Street darling, executing an inversion deal with Actavis and other aggressive acquisitions. As its growth prospects slowed, investors grew restless....
...That transaction, which was worth $160bn, would have allowed Pfizer to redomicile to Ireland by merging into Allergan and allow the US drugmaker to escape US taxes....
...Actavis Holdco U.S., Inc.; Actavis Pharma, Inc.; Ascend Laboratories, LLC; Apotex Corp.; Dr....
...The firm’s original investment in Allergan was a money-spinner, reaping gains of $2.3bn before the company agreed a sale to Actavis....
...However shares in the $84bn US-listed Irish pharma group were held back by the sharp-off in Teva....
...The relevant SEC filings were made by Allergan, Inc. prior to its acquisition by Actavis plc....
...US drugmaker Pfizer plans to continue a legal battle with rival Actavis over the way its blockbuster drug Lyrica is sold in the UK after the Court of Appeal on Thursday rejected a claim of patent infringement...
...In 2013 Ireland-based Warner Chilcott bought US-based Actavis, then in 2015, Actavis bought US-based Allergan....
...Actavis acquired Allergan, which makes the Botox cosmetic, last year and adopted its name after the deal closed....
...Allergan, previously known as Actavis, was itself one of numerous lesser-known US companies to have “redomiciled” to Ireland or other lower-tax countries....
...While generic drugmakers Actavis and Par are expected to appeal against the verdict, Indivior will now have at least another year to launch its successor treatment, a monthly injection, said Deutsche Bank...
...That transaction transformed the company, then known as Actavis, from a manufacturer of generic copycat medicines into a branded drugmaker. “Brent is a bold guy,” says one investor....
...The transaction will rank behind Verizon’s $49bn debt sale in 2013, as well as the $46bn offering from AB InBev and a $21bn issuance from Actavis, Dealogic data show....
...In 2013, US-based Actavis bought Ireland-headquartered Warner Chilcott, paving the way for the company to relocate its tax base away from the US and paved the way for a series of aggressive acquisitions...
...In 2013, US-based Actavis bought Ireland-headquartered Warner Chilcott, paving the way for the company to relocate its tax base away from the US and leading to aggressive acquisitions that culminated in...
...How did we get into this world of corporate flux, in which companies such as Valeant and Actavis, which acquired Allergan and renamed itself, gobble up others before most people have learnt their peculiar...
...Allergan (formerly known as Actavis and before that as Watson) describes itself as pioneering a new model in the drug sector....
...The remarks came in a ruling on Thursday that overturned Pfizer’s UK patent for use of Lyrica against pain and rejected its claim of patent infringement by Actavis, the generic drugs arm of US-based Allergan...
International Edition